Hospital Wanita dan Kanak-Kanak Sabah

Sabak Bernam 88996

0 studies enrolling now · 2 studies all time

What they study most

PD-L1 Positive, Triple Negative Breast Cancer, Uterine Fibroids

Studies at this site

• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer — Running, not enrolling
• Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3) — Stopped early